| CYSB2500085 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2025-04-18 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2500086 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2025-04-18 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2500306 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | New Drug Application | 2025-04-16 | | Yifan Pharmaceutical (Shanghai) Co Ltd | | | view |
| CYSB2500009 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2025-01-09 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2500008 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2025-01-09 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400321 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-12-11 | | Gan & Lee Pharmaceuticals;Gan&Lee Pharmaceuticals Shandong Co Ltd | | | view |
| JYSB2400242 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-11-23 | | Sanofi-Aventis Deutschland GmbH | | | view |
| JYSB2400241 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-11-23 | | Sanofi-Aventis Deutschland GmbH | | | view |
| CYSB2400236 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Zhuhai United Laboratories Co Ltd | | | view |
| CYSB2400237 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Zhuhai United Laboratories Co Ltd | | | view |
| JYSZ2400051 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2024-09-04 | | Sanofi-Aventis Deutschland GmbH;Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| CYSB2400224 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-08-29 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400146 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2024-06-06 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CYSB2400140 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400141 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400113 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-14 | | Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd | | | view |
| JYSB2400080 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-04-08 | | Lilly France;Eli Lilly Nederland BV | | | view |
| JYSB2400079 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-04-08 | | Lilly France;Eli Lilly Nederland BV | | | view |
| CYSB2400040 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-02-09 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400041 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-02-09 | | Gan & Lee Pharmaceuticals | | | view |
